4-108655631-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_021227.4(OSTC):āc.207G>Cā(p.Gln69His) variant causes a missense change. The variant allele was found at a frequency of 0.0000603 in 1,608,298 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 33)
Exomes š: 0.000064 ( 0 hom. )
Consequence
OSTC
NM_021227.4 missense
NM_021227.4 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 5.48
Genes affected
OSTC (HGNC:24448): (oligosaccharyltransferase complex non-catalytic subunit) Predicted to contribute to dolichyl-diphosphooligosaccharide-protein glycotransferase activity. Predicted to be involved in protein N-linked glycosylation via asparagine. Part of oligosaccharyltransferase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSTC | NM_021227.4 | c.207G>C | p.Gln69His | missense_variant | 2/4 | ENST00000361564.9 | NP_067050.1 | |
OSTC | NM_001267818.2 | c.207G>C | p.Gln69His | missense_variant | 2/5 | NP_001254747.1 | ||
OSTC | NM_001267817.2 | c.207G>C | p.Gln69His | missense_variant | 2/3 | NP_001254746.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSTC | ENST00000361564.9 | c.207G>C | p.Gln69His | missense_variant | 2/4 | 1 | NM_021227.4 | ENSP00000354676.4 | ||
OSTC | ENST00000512478.2 | c.207G>C | p.Gln69His | missense_variant | 2/5 | 5 | ENSP00000426167.2 | |||
OSTC | ENST00000613215.4 | c.207G>C | p.Gln69His | missense_variant | 2/3 | 2 | ENSP00000478564.1 | |||
OSTC | ENST00000510556.1 | n.169-1819G>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250338Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135262
GnomAD3 exomes
AF:
AC:
12
AN:
250338
Hom.:
AF XY:
AC XY:
5
AN XY:
135262
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000639 AC: 93AN: 1456098Hom.: 0 Cov.: 29 AF XY: 0.0000497 AC XY: 36AN XY: 724662
GnomAD4 exome
AF:
AC:
93
AN:
1456098
Hom.:
Cov.:
29
AF XY:
AC XY:
36
AN XY:
724662
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74358
GnomAD4 genome
AF:
AC:
4
AN:
152200
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74358
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.207G>C (p.Q69H) alteration is located in exon 2 (coding exon 2) of the OSTC gene. This alteration results from a G to C substitution at nucleotide position 207, causing the glutamine (Q) at amino acid position 69 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;D;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.;L
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;N
REVEL
Uncertain
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
P;.;.
Vest4
MutPred
Loss of sheet (P = 0.1398);Loss of sheet (P = 0.1398);Loss of sheet (P = 0.1398);
MVP
MPC
1.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at